UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.790-798

2010

Volltextzugriff (PDF)

The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet‐mediated fibrinolysis resistance: a thromboelastographic study in whole blood

Journal of thrombosis and haemostasis, 2011-01, Vol.9 (1), p.154-162

2011

Volltextzugriff (PDF)

Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin‐independent impairment of the thrombin‐activatable fibrinolysis inhibitor pathway

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1603-1614

2016

Volltextzugriff (PDF)

Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI‐mediated inhibition of fibrinolysis

Journal of thrombosis and haemostasis, 2013-02, Vol.11 (2), p.315-324

2013

Volltextzugriff (PDF)

Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential

Journal of thrombosis and haemostasis, 2008-09, Vol.6 (9), p.1571-1577

2008

Volltextzugriff (PDF)

U.S. IOOS coastal and ocean modeling testbed: Inter-model evaluation of tides, waves, and hurricane surge in the Gulf of Mexico

Journal of geophysical research. Oceans, 2013-10, Vol.118 (10), p.5129-5172

2013

Volltextzugriff (PDF)

Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.305-313

2016

Volltextzugriff (PDF)

A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression

Journal of thrombosis and haemostasis, 2005-11, Vol.3 (11), p.2554-2562

2005

Volltextzugriff (PDF)

Rebuttal to: Effect of heparin on TAFI‐dependent inhibition of fibrinolysis

Journal of thrombosis and haemostasis, 2003-01, Vol.1 (1), p.202-202

2003

Volltextzugriff (PDF)

Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence

Colorectal disease, 2007-02, Vol.9 (2), p.133-138

2007

Volltextzugriff (PDF)

Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins

Haematologica (Roma), 2009-06, Vol.94 (6), p.819-826

2009

Volltextzugriff (PDF)

Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA

Thrombosis and haemostasis, 2001-04, Vol.85 (4), p.661-666

2001

Volltextzugriff (PDF)

Tissue factor in health and disease

Thrombosis and haemostasis, 1997-07, Vol.78 (1), p.759-764

1997

Volltextzugriff (PDF)

Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection

Thrombosis research, 2005, Vol.116 (6), p.471-477

2005

Volltextzugriff (PDF)

Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis

Hepatology (Baltimore, Md.), 2003-07, Vol.38 (1), p.230-237

2003

Volltextzugriff (PDF)

Cultured human endothelial cells generate tissue factor in response to endotoxin

The Journal of clinical investigation, 1983-06, Vol.71 (6), p.1893-1896

1983

Volltextzugriff (PDF)

Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism

Blood, 2004-03, Vol.103 (6), p.2157-2161

2004

Volltextzugriff (PDF)

Platelets abolish the profibrinolytic effect of activated protein C

Thrombosis and haemostasis, 2000-11, Vol.84 (5), p.922-923

2000

Volltextzugriff (PDF)

Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase‐induced extracellular proteolysis

British journal of haematology, 1999-11, Vol.107 (2), p.294-299

1999

Volltextzugriff (PDF)

Effect of Helicobacter pylori Lipopolysaccharide (LPS) and LPS Derivatives on the Production of Tissue Factor and Plasminogen Activator Inhibitor Type 2 by Human Blood Mononuclear Cells

The Journal of infectious diseases, 1996-12, Vol.174 (6), p.1255-1260

1996

Volltextzugriff (PDF)

Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cells

Thrombosis and haemostasis, 2000-09, Vol.84 (3), p.453-459

2000

Volltextzugriff (PDF)

Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis

Thrombosis and haemostasis, 2006-04, Vol.95 (4), p.606-611

2006

Volltextzugriff (PDF)

Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression

Toxicology and applied pharmacology, 2008-06, Vol.229 (2), p.227-231

2008

Volltextzugriff (PDF)

IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.P-S-464-P-S-464

2007

Volltextzugriff (PDF)

Desmin 370, a low molecular weight dermatan sulfate, reduces the weight of preformed thrombi in rats made afibrinogenemic by ancrod

Thrombosis and haemostasis, 1995-02, Vol.73 (2), p.287-290

1995

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Thrombosis And Haemostasis
(18)
Journal Of Thrombosis And Haemostasis
(15)
Thrombosis Research
(13)
Annals Of The Rheumatic Diseases
(12)
British Journal Of Haematology
(11)
Resuscitation
(11)
Blood
(8)
Agents And Actions
(7)
Fibrinolysis
(7)
Haemostasis
(7)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor

The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet‐mediated fibrinolysis resistance: a thromboelastographic study in whole blood

Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin‐independent impairment of the thrombin‐activatable fibrinolysis inhibitor pathway

Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI‐mediated inhibition of fibrinolysis

Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential

U.S. IOOS coastal and ocean modeling testbed: Inter-model evaluation of tides, waves, and hurricane surge in the Gulf of Mexico

Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran

A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression

Rebuttal to: Effect of heparin on TAFI‐dependent inhibition of fibrinolysis

Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence

Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins

Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA

Tissue factor in health and disease

Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection

Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis

Cultured human endothelial cells generate tissue factor in response to endotoxin

Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism

Platelets abolish the profibrinolytic effect of activated protein C

Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase‐induced extracellular proteolysis

Effect of Helicobacter pylori Lipopolysaccharide (LPS) and LPS Derivatives on the Production of Tissue Factor and Plasminogen Activator Inhibitor Type 2 by Human Blood Mononuclear Cells

Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cells

Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis

Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression

IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A

Desmin 370, a low molecular weight dermatan sulfate, reduces the weight of preformed thrombi in rats made afibrinogenemic by ancrod

Suchergebnisse filtern